147 related articles for article (PubMed ID: 38582623)
1. Cell-free DNA methylation in the clinical management of lung cancer.
Ezegbogu M; Wilkinson E; Reid G; Rodger EJ; Brockway B; Russell-Camp T; Kumar R; Chatterjee A
Trends Mol Med; 2024 May; 30(5):499-515. PubMed ID: 38582623
[TBL] [Abstract][Full Text] [Related]
2. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.
Kim YJ; Jeon H; Jeon S; Lee SH; Kim C; Ahn JH; Um H; Woo YJ; Jeong SH; Kim Y; Park HY; Oh HJ; Cho HJ; Bae JH; Kim JH; An S; Kang SB; Jho S; Biro O; Kis D; Kim BC; Kim Y; Kim JH; Kim BC; Bhak J; Oh IJ
Mol Cell Probes; 2022 Dec; 66():101873. PubMed ID: 36379302
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free DNA sequencing for early detection of lung cancer.
Xue R; Yang L; Yang M; Xue F; Li L; Liu M; Ren Y; Qi Y; Zhao J
Expert Rev Mol Diagn; 2023; 23(7):589-606. PubMed ID: 37318381
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer.
Xu W; Lu J; Zhao Q; Wu J; Sun J; Han B; Zhao X; Kang Y
Dis Markers; 2019; 2019():4108474. PubMed ID: 30867848
[TBL] [Abstract][Full Text] [Related]
8. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Heeke S; Gay CM; Estecio MR; Tran H; Morris BB; Zhang B; Tang X; Raso MG; Rocha P; Lai S; Arriola E; Hofman P; Hofman V; Kopparapu P; Lovly CM; Concannon K; De Sousa LG; Lewis WE; Kondo K; Hu X; Tanimoto A; Vokes NI; Nilsson MB; Stewart A; Jansen M; Horváth I; Gaga M; Panagoulias V; Raviv Y; Frumkin D; Wasserstrom A; Shuali A; Schnabel CA; Xi Y; Diao L; Wang Q; Zhang J; Van Loo P; Wang J; Wistuba II; Byers LA; Heymach JV
Cancer Cell; 2024 Feb; 42(2):225-237.e5. PubMed ID: 38278149
[TBL] [Abstract][Full Text] [Related]
9. Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges.
García-Pardo M; Makarem M; Li JJN; Kelly D; Leighl NB
Br J Cancer; 2022 Sep; 127(4):592-602. PubMed ID: 35347327
[TBL] [Abstract][Full Text] [Related]
10. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
Tomasetti M; Amati M; Neuzil J; Santarelli L
Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
[TBL] [Abstract][Full Text] [Related]
11. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
[TBL] [Abstract][Full Text] [Related]
12. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer.
Wang R; Yang Y; Lu T; Cui Y; Li B; Liu X
PeerJ; 2024; 12():e16802. PubMed ID: 38313016
[TBL] [Abstract][Full Text] [Related]
14. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
Liu L; Toung JM; Jassowicz AF; Vijayaraghavan R; Kang H; Zhang R; Kruglyak KM; Huang HJ; Hinoue T; Shen H; Salathia NS; Hong DS; Naing A; Subbiah V; Piha-Paul SA; Bibikova M; Granger G; Barnes B; Shen R; Gutekunst K; Fu S; Tsimberidou AM; Lu C; Eng C; Moulder SL; Kopetz ES; Amaria RN; Meric-Bernstam F; Laird PW; Fan JB; Janku F
Ann Oncol; 2018 Jun; 29(6):1445-1453. PubMed ID: 29635542
[TBL] [Abstract][Full Text] [Related]
15. Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies.
Magenheim J; Rokach A; Peretz A; Loyfer N; Cann G; Amini H; Moradi P; Nagaraju S; Sameer W; Cohen A; Fogel O; Kuint R; Abutbul A; Abu Rmeileh A; Karameh M; Cohen Goichman P; Wald O; Korach A; Neiman D; Fox-Fisher I; Moss J; Cohen D; Piyanzin S; Ben Ami R; Quteineh A; Golomb E; Shemer R; Glaser B; Kaplan T; Fridlender ZG; Dor Y
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35450968
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.
Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C
Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients.
Bach S; Wever BMM; van de Wiel MA; Veltman JD; Hashemi SMS; Kazemier G; Bahce I; Steenbergen RDM
Epigenetics; 2022 Oct; 17(10):1057-1069. PubMed ID: 34605346
[TBL] [Abstract][Full Text] [Related]
18. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
20. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
